INDV:NASDAQ
Indivior Pharmaceuticals Inc
$34.22
arrow_downward
-2.05%(-0.72) 1D
Sep 8, 12:35:34 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INDV...
Open
$34.35
High
$34.84
Low
$33.84
Mkt. cap
4.04B
Avg. vol.
2.33M
Volume
467.10K
P/E ratio
12.32
52-wk high
$42.81
52-wk low
$22.22
EPS
$2.78
Beta
1.03
Shares outstanding
118.01M
No. of employees
833
Open
$34.35
High
$34.84
Low
$33.84
Mkt. cap
4.04B
Avg. vol.
2.33M
Volume
467.10K
P/E ratio
12.32
52-wk high
$42.81
52-wk low
$22.22
EPS
$2.78
Beta
1.03
Shares outstanding
118.01M
No. of employees
833
News stories
From web sources and news partners
GlobeNewswire
·
2 hours ago
Halper Sadeh LLC is Investigating Whether INDV, FHB, BGMS are Obtaining Fair Deals for their Shareholders
AD HOC NEWS
·
1 day ago
Indivior stock holds steady after recent earnings update
Profile
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
About Indivior Pharmaceuticals Inc
CEOMark Crossley
Employees833
FoundedSep 26, 2014
Headquarters-
SectorPharmaceutical industry
Websiteindivior.com